$NSLR

Neostellar Capital Q3 Earnings Call Highlights

Neostellar Capital (NSLR) reported Q3 investments in AI-related companies, including OpenAI, ClickHouse, and TensorWave. OpenAI's valuation was noted at $852B, with $50B annualized revenue. WHOOP's valuation was adjusted, and Neostellar plans to monetize part of its investment. The company exited several investments, including Learneo and Aventine Property Group, with realized losses. Neostellar ended the quarter with $42.2M in liquid assets and plans to repay debt by year-end.

Original reporting
Published Nov 4, 2026, 2:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 2:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Neostellar Capital Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$NSLRNeutralMed
01

Why it matters

The Q3 call provides the first public disclosure of several portfolio valuations and exit outcomes, offering traders fresh data for pricing the BDC.

02

Market read

Provides new earnings data for a niche BDC; relevance mainly to investors tracking AI‑focused venture exposure.

03

What to watch

Potential upside from monetizing WHOOP exposure and future CoreWeave-related returns not fully reflected in current numbers.

Relevance 7/10Novelty 7/10Timing: post‑earnings today

Background

Neostellar Capital is a business development company focused on late‑stage venture‑backed private tech firms.

Company-level read

Ticker impact

$NSLRNeutralHigh confidence
Context

Q3 earnings call disclosed new investment valuations, exits, and cash position for Neostellar Capital.

Expected impact

likely modest pressure as the market prices in the realized losses and reduced WHOOP exposure.

Evidence & confidence

The earnings call provides fresh quantitative data that can affect valuation; no major surprise but enough detail to influence short‑term price.

Market effects

Highlights continued AI‑infrastructure investment trends affecting venture‑capital BDCs and AI‑related private equities.

Limited to US‑listed BDC investors; no broader regional effect.

Low; the news is company‑specific without macro implications.

Counterpoint

Despite realized losses, the firm’s cash position and ongoing AI exposure could support a rebound if AI spending accelerates.

Key entities

  • Neostellar Capital

    NASDAQ‑listed BDC reporting Q3 results.

Related articles

$NSLRMed

Neostellar Capital Corp. Reports Third Quarter 2026 Financial Results

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Reports Third Quarter 2026 Financial Results Net Asset Value of $12.64 Per Share as of September 30, 2026 Board of Directors Approves Extension of Share Repurchase Program NEW YORK, NY, November 3, 2026 (GLOBE NEWSWIRE) – Neostellar Capital C

$NSLRLow

Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update Net Asset Value Expected to be $12.25 to $12.75 Per Share NEW YORK, NY, October 5, 2026 (GLOBE NEWSWIRE) – Neostellar Capital Corp. (“Neostellar Capital”, the “Company”, “we

$NSLRMed

Neostellar Capital Corp. Reports Second Quarter 2026 Financial Results

Neostellar Capital Corp. (NSLR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Neostellar Capital Corp. Reports Second Quarter 2026 Financial Results An Affiliate of Magnetar Invested $20.0 Million in Neostellar Through a Redeemable Promissory Note Subsequent to Quarter-End Net Asset Value of $13.44 Per Share as of June 30, 2026 NEW YORK, NY, A

$SOPHMed

Sophia Genetics SA (SOPH) (Q3 2026) Earnings Call Highlights: Revenue Surges 25% with Strong

Sophia Genetics SA (SOPH) reported a 25% revenue surge in Q3 2026. CEO Ross Muken expects continued growth in 2027, driven by strong product momentum and a high backlog of customers. The company is investing in medical affairs to drive adoption and has secured notable biopharma collaborations, including with AstraZeneca. CFO George Cardoza emphasized profitability commitments and conservative guidance.

$ONHighAI 8/10

Onsemi delays auto restocking as AI sales jump 175%

Onsemi (ON) reported Q3 revenue of $1.72B, up 11% YoY, with AI data center revenue jumping 175% to $180M. The company is prioritizing AI and industrial chip supply, delaying some automotive restocking orders. Onsemi acquired Ferric for $600M to expand AI power management, raising its 2030 AI revenue target to over $3B. Shares rose 4.78% post-earnings.

$AEHRHighAI 9/10

Aehr Test Systems (AEHR) (Q1 2027) Earnings Call Highlights: Record Revenue, Raised

Aehr Test Systems (AEHR) reported record Q1 2027 revenue of $33M and raised annual guidance to $150M. CEO Gayn Erickson highlighted a potential large burn-in opportunity, estimating $35M-$70M in revenue per million units shipped. The company expects sequential growth in remaining quarters, with Q4 potentially the highest. Management confirmed they are not supply-constrained and can ship more than guided. Silicon carbide revenue was about $10M in fiscal 2026, with expectations for growth in 2027.